INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
DD

Davis Gregory D

Head of Research & TechnologyCIK 0002041855

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 1
Max Insider Score34
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$284
1,630 sh
May 25, 2026May 27, 2026
traded May 25, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SANGAMO THERAPEUTICS, INCHead of Research & Technology · Nov 26, 2025
34
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Open-market sale
SELL
$18K
69.8K sh
Apr 22, 2026
Apr 23, 2026
traded Apr 22, 2026
+1d
SEC FORM 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Grant or award
A—
225.0K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$393
832 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$2,406
5,119 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC FORM 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$3,077
7,721 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$301
723 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence